APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bilastine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Bilastine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025182 pages

Choose your research edition.

Industry ResearchBilastine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Bilastine Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Bilastine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bilastine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Bilastine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Bilastine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Bilastine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bilastine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bilastine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Bilastine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bilastine include Aralez Pharmaceuticals, Berlin Chemie, Faes Farma, Menarini, Pierre Fabre, Taiho Yakuhin, GlaxoSmithKline and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bilastine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bilastine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bilastine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bilastine market size, projected growth trends, production technologies, key applications, and end-use industries.

Bilastine Segment by Company

Aralez Pharmaceuticals

Berlin Chemie

Faes Farma

Menarini

Pierre Fabre

Taiho Yakuhin

GlaxoSmithKline

Takeda

Bilastine Segment by Type

Hospital

Drug Store

Bilastine Segment by Application

Allergic Rhinoconjunctivitis

Allergic Rhinitis

Urticaria

Bilastine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bilastine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bilastine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bilastine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bilastine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bilastine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Bilastine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Bilastine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Bilastine Industry Trends Table 2. Bilastine Industry Drivers Table 3. Bilastine Industry Opportunities and Challenges Table 4. Bilastine Industry Restraints Table 5. Global Bilastine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Bilastine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Bilastine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Bilastine Sales Market Share by Manufacturers Table 9. Global Bilastine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Bilastine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Bilastine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Bilastine Manufacturers, Product Type & Application Table 13. Global Bilastine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Bilastine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Hospital Table 17. Major Manufacturers of Drug Store Table 18. Global Bilastine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Bilastine Sales by Type (2021-2026) & (K Units) Table 20. Global Bilastine Sales by Type (2027-2032) & (K Units) Table 21. Global Bilastine Sales Market Share by Type (2021-2026) Table 22. Global Bilastine Sales Market Share by Type (2027-2032) Table 23. Global Bilastine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Bilastine Revenue by Type (2021-2026) & (K Units) Table 25. Global Bilastine Revenue by Type (2027-2032) & (K Units) Table 26. Global Bilastine Revenue Market Share by Type (2021-2026) Table 27. Global Bilastine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Allergic Rhinoconjunctivitis Table 29. Major Manufacturers of Allergic Rhinitis Table 30. Major Manufacturers of Urticaria Table 31. Global Bilastine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Bilastine Sales by Application (2021-2026) & (K Units) Table 33. Global Bilastine Sales by Application (2027-2032) & (K Units) Table 34. Global Bilastine Sales Market Share by Application (2021-2026) Table 35. Global Bilastine Sales Market Share by Application (2027-2032) Table 36. Global Bilastine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Bilastine Revenue by Application (2021-2026) & (K Units) Table 38. Global Bilastine Revenue by Application (2027-2032) & (K Units) Table 39. Global Bilastine Revenue Market Share by Application (2021-2026) Table 40. Global Bilastine Revenue Market Share by Application (2027-2032) Table 41. Global Bilastine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Bilastine Sales by Region (2021-2026) & (K Units) Table 43. Global Bilastine Sales Market Share by Region (2021-2026) Table 44. Global Bilastine Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Bilastine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Bilastine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Bilastine Sales by Country (2021-2026) & (K Units) Table 48. North America Bilastine Sales by Country (2027-2032) & (K Units) Table 49. Europe Bilastine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Bilastine Sales by Country (2021-2026) & (K Units) Table 51. Europe Bilastine Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Bilastine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Bilastine Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Bilastine Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Bilastine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Bilastine Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Bilastine Sales by Country (2027-2032) & (K Units) Table 58. Global Bilastine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Bilastine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Bilastine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Bilastine Revenue Market Share by Region (2021-2026) Table 62. Global Bilastine Revenue Market Share by Region (2027-2032) Table 63. Aralez Pharmaceuticals Company Information Table 64. Aralez Pharmaceuticals Business Overview Table 65. Aralez Pharmaceuticals Bilastine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Aralez Pharmaceuticals Bilastine Product Portfolio Table 67. Aralez Pharmaceuticals Recent Development Table 68. Berlin Chemie Company Information Table 69. Berlin Chemie Business Overview Table 70. Berlin Chemie Bilastine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Berlin Chemie Bilastine Product Portfolio Table 72. Berlin Chemie Recent Development Table 73. Faes Farma Company Information Table 74. Faes Farma Business Overview Table 75. Faes Farma Bilastine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Faes Farma Bilastine Product Portfolio Table 77. Faes Farma Recent Development Table 78. Menarini Company Information Table 79. Menarini Business Overview Table 80. Menarini Bilastine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Menarini Bilastine Product Portfolio Table 82. Menarini Recent Development Table 83. Pierre Fabre Company Information Table 84. Pierre Fabre Business Overview Table 85. Pierre Fabre Bilastine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Pierre Fabre Bilastine Product Portfolio Table 87. Pierre Fabre Recent Development Table 88. Taiho Yakuhin Company Information Table 89. Taiho Yakuhin Business Overview Table 90. Taiho Yakuhin Bilastine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Taiho Yakuhin Bilastine Product Portfolio Table 92. Taiho Yakuhin Recent Development Table 93. GlaxoSmithKline Company Information Table 94. GlaxoSmithKline Business Overview Table 95. GlaxoSmithKline Bilastine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. GlaxoSmithKline Bilastine Product Portfolio Table 97. GlaxoSmithKline Recent Development Table 98. Takeda Company Information Table 99. Takeda Business Overview Table 100. Takeda Bilastine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Takeda Bilastine Product Portfolio Table 102. Takeda Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Bilastine Distributors List Table 106. Bilastine Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Bilastine Product Image Figure 2. Global Bilastine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bilastine Market Size (2021-2032) & (US$ Million) Figure 4. Global Bilastine Sales (2021-2032) & (K Units) Figure 5. Global Bilastine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Bilastine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Hospital Image Figure 9. Drug Store Image Figure 10. Global Bilastine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Bilastine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Bilastine Sales Market Share by Type (2021-2032) Figure 13. Global Bilastine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Bilastine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Bilastine Revenue Market Share by Type (2021-2032) Figure 16. Allergic Rhinoconjunctivitis Image Figure 17. Allergic Rhinitis Image Figure 18. Urticaria Image Figure 19. Global Bilastine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Bilastine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Bilastine Sales Market Share by Application (2021-2032) Figure 22. Global Bilastine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Bilastine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Bilastine Revenue Market Share by Application (2021-2032) Figure 25. North America Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Bilastine Sales Market Share by Country (2021-2032) Figure 27. U.S. Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Bilastine Sales Market Share by Country (2021-2032) Figure 32. Germany Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Bilastine Sales Market Share by Country (2021-2032) Figure 39. China Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Bilastine Sales Market Share by Country (2021-2032) Figure 47. Brazil Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Bilastine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Bilastine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Bilastine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Bilastine Revenue (2021-2032) & (US$ Million) Figure 58. North America Bilastine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Bilastine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Bilastine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Bilastine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Bilastine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Bilastine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Bilastine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Bilastine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Bilastine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Hospital
  • Drug Store
Applications
  • Allergic Rhinoconjunctivitis
  • Allergic Rhinitis
  • Urticaria
Companies covered
  • Aralez Pharmaceuticals
  • Berlin Chemie
  • Faes Farma
  • Menarini
  • Pierre Fabre
  • Taiho Yakuhin
  • GlaxoSmithKline
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bilastine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bilastine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Bilastine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Bilastine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Bilastine Market Dynamics
  1. 2.1 Bilastine Industry Trends
  2. 2.2 Bilastine Industry Drivers
  3. 2.3 Bilastine Industry Opportunities and Challenges
  4. 2.4 Bilastine Industry Restraints
3 Bilastine Market by Manufacturers
  1. 3.1 Global Bilastine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Bilastine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Bilastine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Bilastine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bilastine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Bilastine Manufacturers, Product Type & Application
  7. 3.7 Global Bilastine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bilastine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bilastine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bilastine Tier 1, Tier 2, and Tier 3
4 Bilastine Market by Type
  1. 4.1 Bilastine Type Introduction
  2. 4.1.1 Hospital
  3. 4.1.2 Drug Store
  4. 4.2 Global Bilastine Sales by Type
  5. 4.2.1 Global Bilastine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bilastine Sales by Type (2021-2032)
  7. 4.2.3 Global Bilastine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Bilastine Revenue by Type
  9. 4.3.1 Global Bilastine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bilastine Revenue by Type (2021-2032)
  11. 4.3.3 Global Bilastine Revenue Market Share by Type (2021-2032)
5 Bilastine Market by Application
  1. 5.1 Bilastine Application Introduction
  2. 5.1.1 Allergic Rhinoconjunctivitis
  3. 5.1.2 Allergic Rhinitis
  4. 5.1.3 Urticaria
  5. 5.2 Global Bilastine Sales by Application
  6. 5.2.1 Global Bilastine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bilastine Sales by Application (2021-2032)
  8. 5.2.3 Global Bilastine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Bilastine Revenue by Application
  10. 5.3.1 Global Bilastine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Bilastine Revenue by Application (2021-2032)
  12. 5.3.3 Global Bilastine Revenue Market Share by Application (2021-2032)
6 Global Bilastine Sales by Region
  1. 6.1 Global Bilastine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bilastine Sales by Region (2021-2032)
  3. 6.2.1 Global Bilastine Sales by Region (2021-2026)
  4. 6.2.2 Global Bilastine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bilastine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Bilastine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Bilastine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Bilastine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Bilastine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Bilastine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Bilastine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Bilastine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Bilastine Revenue by Region
  1. 7.1 Global Bilastine Revenue by Region
  2. 7.1.1 Global Bilastine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Bilastine Revenue by Region (2021-2026)
  4. 7.1.3 Global Bilastine Revenue by Region (2027-2032)
  5. 7.1.4 Global Bilastine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Bilastine Revenue (2021-2032)
  8. 7.2.2 North America Bilastine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Bilastine Revenue (2021-2032)
  11. 7.3.2 Europe Bilastine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Bilastine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Bilastine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Bilastine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Bilastine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aralez Pharmaceuticals
  2. 8.1.1 Aralez Pharmaceuticals Company Information
  3. 8.1.2 Aralez Pharmaceuticals Business Overview
  4. 8.1.3 Aralez Pharmaceuticals Bilastine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aralez Pharmaceuticals Bilastine Product Portfolio
  6. 8.1.5 Aralez Pharmaceuticals Recent Developments
  7. 8.2 Berlin Chemie
  8. 8.2.1 Berlin Chemie Company Information
  9. 8.2.2 Berlin Chemie Business Overview
  10. 8.2.3 Berlin Chemie Bilastine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Berlin Chemie Bilastine Product Portfolio
  12. 8.2.5 Berlin Chemie Recent Developments
  13. 8.3 Faes Farma
  14. 8.3.1 Faes Farma Company Information
  15. 8.3.2 Faes Farma Business Overview
  16. 8.3.3 Faes Farma Bilastine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Faes Farma Bilastine Product Portfolio
  18. 8.3.5 Faes Farma Recent Developments
  19. 8.4 Menarini
  20. 8.4.1 Menarini Company Information
  21. 8.4.2 Menarini Business Overview
  22. 8.4.3 Menarini Bilastine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Menarini Bilastine Product Portfolio
  24. 8.4.5 Menarini Recent Developments
  25. 8.5 Pierre Fabre
  26. 8.5.1 Pierre Fabre Company Information
  27. 8.5.2 Pierre Fabre Business Overview
  28. 8.5.3 Pierre Fabre Bilastine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pierre Fabre Bilastine Product Portfolio
  30. 8.5.5 Pierre Fabre Recent Developments
  31. 8.6 Taiho Yakuhin
  32. 8.6.1 Taiho Yakuhin Company Information
  33. 8.6.2 Taiho Yakuhin Business Overview
  34. 8.6.3 Taiho Yakuhin Bilastine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Taiho Yakuhin Bilastine Product Portfolio
  36. 8.6.5 Taiho Yakuhin Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline Bilastine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Bilastine Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 Takeda
  44. 8.8.1 Takeda Company Information
  45. 8.8.2 Takeda Business Overview
  46. 8.8.3 Takeda Bilastine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Takeda Bilastine Product Portfolio
  48. 8.8.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bilastine Value Chain Analysis
  2. 9.1.1 Bilastine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bilastine Production Mode & Process
  6. 9.2 Bilastine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bilastine Distributors
  9. 9.2.3 Bilastine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst